CRCM  Vol.2 No.4 , July 2013
Burkitt’s lymphoma presenting with rapidly and multi-organ involvement: A case presentation
Abstract: Burkitt lymphoma is an aggressive lymphoma and its clinical, immunologic, chemical features are well-known. Burkitt lymphoma is in highgrade lymphomas and can spread very rapidly. Burkitt lymphoma has been difficult to be cured with conventional chemotherapy for adults. Early autologous bone marrow should be kept in mind in first remission BL. We presented a case of presenting with rapid and multi organ involvement with BL. A 55-year-old male patient responded to the conventional chemotherapy for short-term and died 9 months after diagnosis because of relapse of Burkitt lymphoma.
Cite this paper: Berber, I. , Erkurt, M. , Koroglu, M. , Kuku, I. , Kaya, E. and Bentli, R. (2013) Burkitt’s lymphoma presenting with rapidly and multi-organ involvement: A case presentation. Case Reports in Clinical Medicine, 2, 242-245. doi: 10.4236/crcm.2013.24066.

[1]   Burkitt, D.P. (1983) The discovery of Burkitt’s lymphoma. Cancer, 51, 1777-1786. doi:10.1002/1097-0142(19830515)51:10<1777::AID-CNCR2820511003>3.0.CO;2-E

[2]   Armitage, J.O. and Weisenburger, D.D. (1998) New approach to classifying non-Hodgkin’s lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. Journal of Clinical Oncology, 16, 2780-2795.

[3]   Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., et al. (2008) Cancer statistics. Cancer Statistics, 58, 71-96. doi:10.3322/CA.2007.0010

[4]   Anderson, J.R., Jenkin, R.D., Wilson, J.F., Kjeldsberg, C.R., Sposto, R., Chilcote, R.R., et al. (1993) Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: A report of CCG-551 from the Childrens Cancer Group. Journal of Clinical Oncology, 11, 1024-1032.

[5]   Blum, K.A., Lozanski, G. and Byrd, J.C. (2004) Adult Burkitt leukemia and lymphoma. Blood, 104, 3009-3020. doi:10.1182/blood-2004-02-0405

[6]   Evens, A.M. and Gordon, L.I. (2002) Burkitt’s and Burkitt-like lymphoma. Current Treatment Options in Oncology, 3, 291-305. doi:10.1007/s11864-002-0029-9

[7]   Fenaux, P., Bourhis, J.H. and Ribrag, V. (2001) Burkitt’s acute lymphocytic leukemia (L3ALL) in adults. Hematology/Oncology Clinics of North America, 15, 37-50. doi:10.1016/S0889-8588(05)70199-4

[8]   Soussain, C., Patte, C., Ostronoff, M., Delmer, A., Rigal-Huguet, F., Cambier, N., et al., (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood, 85, 664-674.

[9]   Sweetenham, J.W., Pearce, R., Taghipour, G., Blaise, D., Gisselbrecht, C. and Goldstone, A.H. (1996) Adult Burkitt’s and Burkitt-like non-Hodgkin’s lymphoma—Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the European Group for blood and marrow transplantation. Journal of Clinical Oncology, 14, 2465-2472.

[10]   Nademanee, A., Molina, A., O’Donnell, M.R., Dagis, A., Snyder, D.S., Parker, P., et al. (1997) Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group. Blood, 90, 3844-3852.

[11]   Van Imhoff, G.W., van der Holt, B., MacKenzie, M.A., Ossenkoppele, G.J., Wijermans, P.W., Kramer, M.H., et al., (2005) Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia, 19, 945-952. doi:10.1038/sj.leu.2403733

[12]   Nademanee, A., Molina, A., Dagis, A., Snyder, D.S., O’Donnell, M.R., Parker, P., et al., (2000) Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma. Clinical Lymphoma, 1, 46-54. doi:10.3816/CLM.2000.n.004